Telix Pharmaceuticals Limited

ASX:TLX Stock Report

Market Cap: AU$7.6b

Telix Pharmaceuticals Limited Company Information

Telix Pharmaceuticals Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Telix Pharmaceuticals Limited
  • Ticker: TLX
  • Exchange: ASX
  • Founded: 2015
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: AU$7.557b
  • Shares Outstanding: 334.68m
  • Website: https://telixpharma.com

Number of Employees


Location

  • Telix Pharmaceuticals Limited
  • 55 Flemington Road
  • Suite 401
  • North Melbourne
  • Victoria
  • 3051
  • Australia


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
TLXASX (Australian Securities Exchange)YesOrdinary SharesAUAUDNov 2017
TLXCHIA (Chi-X Australia)YesOrdinary SharesAUAUDNov 2017
TLPP.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDNov 2017
T3XDB (Deutsche Boerse AG)YesOrdinary SharesDEEURNov 2017
TLXNasdaqGS (Nasdaq Global Select)SPONSORED ADSUSUSDNov 2024

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/24 19:43
End of Day Share Price 2024/11/22 00:00
Earnings2024/06/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.